
Mexico buys oral treatment against COVID-19 from Pfizer...
The treatment reduces the risk of hospitalization or death by 89%, when started within three days of the onset of symptoms.

The treatment reduces the risk of hospitalization or death by 89%, when started within three days of the onset of symptoms.